PAG
MYGN icon

Private Advisor Group’s Myriad Genetics MYGN Stock Holding History

Private Advisor Group’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,297
Closed -$74.4K – 2714
2025
Q3 		$74.4K Buy
+10,297
New +$61.1K ﹤0.01% 2431
2020
Q3 		– Sell
-640
Closed -$7K – 2746
2020
Q2 		$7K Buy
+640
New +$9.09K ﹤0.01% 3091
2014
Q4 		– Sell
-16,516
Closed -$637K – 1182
2014
Q3 		$637K Sell
16,516
-3,753
-19% -$140K 0.04% 441
2014
Q2 		$789K Buy
20,269
+4,141
+26% +$154K 0.07% 350
2014
Q1 		$551K Buy
+16,128
New +$500K 0.06% 390

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Private Advisor Group's MYGN Position: Q4 2025 in Review

Private Advisor Group sold out of Myriad Genetics (MYGN) in Q4 2025, closing a stake of 10,297 shares — an estimated $74.4K sold.

Private Advisor Group first reported a position in MYGN in Q1 2014 and held it in 5 quarters. The position peaked at $789K in Q2 2014. 221 funds tracked by Wall St. Rank hold MYGN as of Q4 2025.

  • Private Advisor Group reported no remaining Myriad Genetics position as of Q4 2025 after selling out during the quarter.
  • Private Advisor Group sold 10,297 Myriad Genetics shares in Q4 2025, an estimated $74.4K.
  • Private Advisor Group first reported a position in Myriad Genetics in Q1 2014 and held it in 5 quarters.
  • Private Advisor Group's Myriad Genetics position peaked at $789K in Q2 2014.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2025.

Based on Private Advisor Group's 13F filing for Q4 2025, filed 17 Feb 2026.